Atlas Trials

Reduce Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed Multiple Myeloma

Clinical trial NCT04205240 · TERMINATED

Trial details

NCT number
NCT04205240
Sponsor
Srinivas Devarakonda
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Recurrent Plasma Cell Myeloma
Start date
2020-12-22
Primary completion
2021-05-08
Enrollment
1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.